Edward B. Garon

Also affiliated with University of Santa Monica, Translational Research in Oncology, Cancer Clinic

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer”.

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

New England Journal of Medicine(2018)10.1056/nejmoa1801005

N/A

1.3DataRank · unranked

6524 citations

Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis +34 more

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet(2016)10.1016/s0140-6736(15)01281-7

N/A

1.3DataRank · unranked

6497 citations

Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han +20 more

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.007

N/A

0.568DataRank · unranked

43 citations

Alan Nicholas, G. Alexander Patterson, Salama N. Waqar, Eric M. Toloza, Eric B. Haura +24 more

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

Nature Medicine(2024)10.1038/s41591-024-03240-y

N/A

0.546DataRank · unranked

37 citations

Nadeem Riaz, Prerana Bangalore Parthasarathy, Vladimir Makarov, Sviatoslav M. Kendall, Seong‐Keun Yoo +16 more

Consent document translation expense hinders inclusive clinical trial enrolment

Nature(2023)10.1038/s41586-023-06382-0

N/A

0.520DataRank · unranked

31 citations

Beth A. Glenn, Maria García-Jímenez, Amy L. Cummings, Aaron Lisberg, Andrea Nañez +14 more

Characteristics of a CCL21 Gene–Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non–Small Cell Lung Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0435

N/A

0.373DataRank · unranked

11 citations

Camelia Dumitras, Ramin Salehi‐Rad, Linh M. Tran, Kostyantyn Krysan, Raymond J. Lim +7 more

Circulating tumor DNA (ctDNA) mutations may predict treatment response in extensive-stage small cell lung cancer (ES-SCLC) treated with talazoparib and temozolomide (TMZ).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8564

N/A

0.225DataRank · unranked

2 citations

Amy L. Cummings, Melody Mendenhall, David E. Kanamori, Andrew Nguyen, David Dae-Young Kim +12 more

Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100150

N/A

0DataRank · unranked

6 citations

Diana C. Márquez‐Garbán, Zorawar S. Noor, Neda A. Moatamed, David Elashoff, Tristan Grogan +9 more

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1386

N/A

0DataRank · unranked

29 citations

Aaron Lisberg, Alejandro J. Garcia, Samuel Granjeaud, Anne Madroszyk, Stéphane Fattori +13 more

Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2305236120

N/A

0DataRank · unranked

76 citations

Weihua Zeng, Xiaohui Ni, Qiao Liu, Wenyuan Li, Mary L. Stackpole +17 more

CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006896

N/A

0DataRank · unranked

31 citations

Raymond J. Lim, Yushen Du, Linh M. Tran, Rui Li, Stephanie L Ong +17 more

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100205

N/A

0DataRank · unranked

84 citations

Roy S. Herbst, Gilberto de Castro, Rina Hui, Nir Peled, Dong‐Wan Kim +12 more

Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100468

N/A

0DataRank · unranked

9 citations

Michael Xiang, Stephanie Yoon, Alan Lee, Dan Ruan, Jonathan W. Goldman +5 more

Data from Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

(2023)10.1158/1078-0432.c.6520385.v1

N/A

0DataRank · unranked

0 citations

David S. Boss, D. Ross Camidge, Carolyn D. Britten, Jeffrey A. Engelman, Edward B. Garon +9 more

Data from Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

(2023)10.1158/1078-0432.c.6520385

N/A

0DataRank · unranked

0 citations

David S. Boss, D. Ross Camidge, Carolyn D. Britten, Jeffrey A. Engelman, Edward B. Garon +9 more

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

Frontiers in Immunology(2020)10.3389/fimmu.2020.01036

N/A

0DataRank · unranked

15 citations

Alejandro J. Garcia, Brice Chanez, Anne Madroszyk, Daniel Olive, Edward B. Garon +1 more

The Role of Interleukin 1β in the Pathogenesis of Lung Cancer

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100001

N/A

0DataRank · unranked

61 citations

James Chih‐Hsin Yang, Steven M. Dubinett, Edward B. Garon